As full disclosure nears, doctors’ pay for drug talks plummets
March 5, 2014
As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies in the US will be required to report payments to doctors
Charles Ornstein, Eric Sagara and Ryann Grochowski Jones
Some of the US’ largest pharmaceutical companies have slashed payments to health professionals for promotional speeches amid heightened public scrutiny of such spending, a new ProPublica analysis shows.
.jpg "MoneyLife")
